肺癌立体定向放疗中形变剂量映射与累加技术的深度解读
本文对肺癌立体定向放疗(SBRT)中基于形变图像配准(DIR)的剂量映射与累加技术进行了批判性综述,重点阐述方法学原理、临床应用、局限性及实践指导。当解剖结构变化较大时(如肿瘤退缩、再程放疗),剂量映射可能产生显著误差并传播至合成剂量分布,尤其在陡峭剂量梯度区域。目前缺乏标准化基准和验证工具,质控框架的建立对安全实施至关重要。
要点
- DIR剂量累加在解剖变化大时误差显著,再程放疗中应谨慎使用。
- 生物力学模型联合能量/质量一致映射更能保留物理原理。
- 缺乏标准化基准和验证工具,质控框架建立至关重要。
核心结论
- 基于DIR的剂量映射与累加是肺癌SBRT的重要工具,但解剖变化大时误差显著,临床应保守应用并遵循协作组指南。
研究设计与样本
- 本文为批判性综述,对文献进行了广泛评估,重点关注DIR算法及相关剂量映射策略(直接剂量映射、体素变形、能量/质量一致映射),并在运动管理、自适应放疗和再程放疗等临床场景中审视这些方法。
主要发现
- 当解剖变化较大时(如肿瘤退缩、质量和密度变化,尤其在再程放疗场景中),可发生显著误差,并传播至映射和合成剂量分布,在陡峭剂量梯度区域导致不准确。
- 生物力学模型联合能量/质量一致映射在解剖变化较大时更能保留物理原理。
- 由于缺乏标准化基准,质量保证仍具挑战性,临床中验证DIR和形变剂量累加准确性的工具严重缺乏。
临床怎么用
- 临床医生应保守应用基于DIR的剂量累加,尤其在再程放疗中解剖变化显著时,因合成剂量存在显著不确定性。
- 每个临床病例应仔细评估风险/获益,临床应用应遵循协作组指南。
- 剂量累加方法的标准化将增强剂量-体积-效应建模。
局限性
- 缺乏标准化基准和临床验证DIR及形变剂量累加准确性的工具,质量保证框架尚未建立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Deformable dose mapping and accumulation are essential tools in lung cancer stereotactic body radiation therapy (SBRT). Here, we provide a critical review of deformable image registration (DIR)-based dose mapping and accumulation techniques in SBRT for lung cancers, with emphasis on methodological principles, clinical applications, limitations, and guidance for practice. A broad appraisal of the literature was conducted, emphasizing DIR algorithms and related dose mapping strategies, including direct dose mapping, voxel warping, and energy/mass-congruent mapping. These methods were examined across key clinical scenarios for lung SBRT planning, including motion management, adaptive radiation therapy and reirradiation. Significant errors can occur when anatomic changes are large, such as tumor regression, mass and density variations, etc., as observed in reirradiation scenarios. These errors will propagate to the mapped and composite dose distributions, particularly in steep dose gradients, resulting in inaccuracies. Biomechanical models combined with energy/mass-congruent mapping better preserve physical principles under such conditions. Quality assurance remains challenging due to the absence of standardized benchmarks. Tools for validation of DIR and deformable dose accumulation accuracy in the clinic are severely lacking. The development of quality assurance frameworks is critical to safe implementation. Clinicians should apply DIR-based dose accumulation conservatively, particularly when anatomy changes considerably in reirradiation settings, given the potential for significant uncertainties in the composite doses. Each clinical case should be viewed carefully by assessing the risk/benefit, and clinical application should follow cooperative group guidelines. Standardization of methods for dose accumulation will enhance dose-volume-effect modeling.
引用
- Chetty IJ, Zhong H. Deformable Dose Mapping and Accumulation Techniques for Stereotactic Body Radiation Therapy (SBRT) of Lung Cancers. Int J Radiat Oncol Biol Phys. 2026. PMID: 41587700. doi:10.1016/j.ijrobp.2026.01.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。